Oregon
Oregon
-
Read ArticleCan photo-immunotherapy improve outcomes in advanced solid tumors?
Providence Cancer Institute to offer a new phase I/II study of a first-in-class photoimmunotherapy for solid tumors that overexpress the epidermal growth factor receptor protein.
-
Read ArticleProvidence cancer research featured at global oncology conference
Researchers at the Earle A. Chiles Research Institute, a division of Providence Cancer Institute, will join oncology professionals around the world for the 2021 ASCO Annual Virtual Conference.
-
Read ArticleKuni Foundation grant supports Providence study of breast cancer screening disparities
Researchers at Providence’s Center for Outcomes Research and Education (CORE) have received a $430,000 Kuni Foundation grant to study disparities in cancer screenings.
-
Read ArticleDr. Walter Urba shares his personal path to Providence
Immunology leader Dr. Walter Urba talks about his healthcare journey and how Providence is defining the future of personalized care.
-
Read ArticlePhase II study of neoadjuvant combination therapy for ovarian cancer
Providence Cancer Institute to offer phase II clinical trial of neoadjuvant chemotherapy plus immunotherapy for patients with advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer.
- GET THE APP ›
-
Read ArticleKaiser, Providence and Medical Teams International partner in vaccine equity efforts
Portland’s first African American Baptist church, Mt. Olivet, has opened a temporary vaccination clinic, funded by Providence Health & Services and Kaiser Permanente.
-
Read ArticleNoteworthy - April 2021
Learn about important news from Providence Heart and Cancer institutes, CME opportunities, the new “Doc Talks” series and more.
-
Read ArticleConfronting climate change to protect health
“Get out and exercise in the fresh air, drink plenty of (clean) water, and eat healthy, fresh foods.” This is common advice we give our patients, families and ourselves to maintain and improve health.
- FIND A DOCTOR ›
-
Read ArticleColorectal cancer increases in younger populations, emphasizing importance of screenings
Newly published data show a significant increase in the incidence of colorectal cancer among younger populations.
-
Read ArticleSouthern Oregon community vaccination site for ages 16 and older
Two important things for you to know: 1. Vaccinations are free and appointments are encouraged. 2. You do not need health insurance or identification.
-
Read ArticleChanging my perception of homelessness
Providence's Glenda Fossum-Smith shares how one experience changed her view of the homelessness pandemic.
-
Read ArticlePeople of Providence
- LEARN MORE
-
Read ArticleUpcoming Events
-
Read ArticleGrateful patients thank providers, care teams
Being a provider or other member of the care team requires years of training, sometimes long hours, and emotional conversations with patients and their families.
- FIND A CLINIC ›
-
Read ArticleProvidence leadership changes
Read about new leadership changes at Providence that affect providers and care teams.
-
Read ArticleDr. Marka Crittenden receives honor to further research at Providence Cancer Institute
Providence Cancer Institute’s Marka Crittenden, M.D., Ph.D., has been named the recipient of the new Michael Kelley Endowed Chair for Cancer Research.
-
Read ArticleConfronting climate change to protect health
“Get out and exercise in the fresh air, drink plenty of (clean) water, and eat healthy, fresh foods.” This is common advice we give our patients, families and ourselves to maintain and improve health.
-
Read ArticleWe celebrate you on Doctors’ Day – March 30, 2021
This year, the annual Doctors’ Day takes on additional meaning. The past year of COVID-19 has brought challenges no one could have anticipated or prepared for.
-
Read ArticleProvidence researchers demonstrate antibodies to COVID-19 in breast milk of mothers following vaccination
Learn about a potential immune benefit for infants from lactating mothers who have received a COVID-19 vaccine.
-
Read ArticleCombination therapy for metastatic thyroid cancer
New clinical trial at Providence Cancer Institute combining targeted therapy with checkpoint immunotherapy for patients with metastatic thyroid cancer.
-
Loading More...
